AMKOR TECHNOLOGY, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data AMKOR TECHNOLOGY, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	3,928	4,207	4,316	4,053	5,051	6,138	7,092	6,503	6,318	6,708
Cost of revenue	3,218	3,446	3,606	3,403	4,150	4,913	5,762	5,560	5,384	5,769
Gross profit	710	761	711	649	901	1,226	1,330	943	933	939
Research and development	117	167	157	138	141	166	149	177	163	167
Selling, general and administrative	284	297	295	279	303	296	283	295	332	304
Operating expenses	401	356	452	416	444	462	433	473	495	471
Operating income	309	406	258	233	457	763	897	470	438	467
Interest expense	79.7	83.8	78.9		64.2	51.5	58.6	59	64.9	75.4
Other non-operating income	-78.9	-98	-72.3	-73.4	-70.6	-48.4	-40.3	-26.4	-7.44	-22.8
Pre-tax income	230	307	186	160	387	715	857	444	431	445
Income tax	51	39.8	56.3	37.2	46.2	69.5	89.9	81.7	75.5	68.5
Net income to minority interests	3.12	4.16	2.47	1.74	2.36	2.61	1.22	2.32	1.52	2.22
Net income	176	264	127	121	338	643	766	360	354	374
EBITDA	864	987	830	757	968	1,327	1,510	1,102	1,033	1,109
EPS, basic	0.74	1.10	0.53	0.50	1.40	2.64	3.13	1.46	1.44	1.51
EPS, diluted	0.74	1.10	0.53	0.50	1.40	2.62	3.11	1.46	1.43	1.50
Shares, basic (weighted)	237	239	239	240	242	244	245	246	246	247
Shares, diluted (weighted)	238	240	240	240	242	246	246	247	248	248
Dividend per share					0.04	0.17	0.23	0.30	0.72	0.33

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	550	596	682	895	698	827	959	1,120	1,134	1,378
Short-term investments				6.35	134	252	282	475	513	613
Receivables	563	798	724	851	963	1,259	1,366	1,149	1,055	1,355
Inventory	268	214	231	221	297	485	630	393	311	438
Other current assets	27.1	33.7	32	28.3	40.2	33.6	65.1	58.5	61	101
Total current assets	1,410	1,644	1,671	2,002	2,133	2,857	3,301	3,196	3,073	3,885
Property, plant and equipment	2,565	2,695	2,650	2,405	2,566	2,871	3,136	3,299	3,576	3,871
Lease right-of-use assets			0	149	147	160	171	117	110	93.4
Goodwill	24.1	25	25.7	26	27.3	24.5	21.5	20	17.9	18
Other non-current assets	89.6	140	144	112	146	123	189	138	166	202
Total assets	4,092	4,508	4,495	4,696	5,022	6,039	6,822	6,771	6,944	8,136
Accounts payable	487	569	530	571	636	829	899	754	713	913
Accrued liabilities	339	331	258	267	299	423	402	358	356	370
Deferred revenue			16.7	16.2	30.3	118	81.5	71.1	59.7	69.6
Short-term debt	35.2	124	115	144	149	153	144	132	236	162
Total current liabilities	1,006	1,318	1,158	1,060	1,316	1,680	1,662	1,384	1,455	1,712
Long-term debt	1,365	1,241	1,218	1,306	1,005	985	1,089	1,072	923	1,283
Lease liabilities			0	91.1	84.4	83.9	75.7	56.8	58	48.5
Other non-current liabilities	76.7	47.8	79.1	71.7	103	197	202	176	254	517
Total liabilities	2,689	2,789	2,640	2,705	2,668	3,066	3,122	2,776	2,761	3,630
Total debt	1,365	1,241	1,334	1,460	1,164	1,147	1,089	1,072	923	1,283
Paid-in capital	1,895	1,903	1,909	1,928	1,953	1,977	1,996	2,008	2,032	2,054
Retained earnings	-304	-13.9	113	234	563	1,164	1,875	2,160	2,335	2,627
Treasury stock	-214	-216	-216	-217	-218	-219	-219	-222	-225	-227
Other comprehensive income	6.26	22.5	23.8	19.1	27.3	20	16.7	16.4	7.51	16.8
Shareholders' equity	1,384	1,696	1,831	1,964	2,326	2,942	3,669	3,962	4,150	4,471
Minority interests	19.8	23.4	25.4	26.5	28.3	30.3	30.9	32.7	33.6	35.2
Total equity	1,430	1,720	1,856	1,990	2,354	2,973	3,700	3,995	4,183	4,506
Total liabilities and equity	4,092	4,508	4,495	4,696	5,022	6,039	6,822	6,771	6,944	8,136
Shares outstanding	0.24	0.24	239	241	243	244	245	246	247	247

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	179	268	130	123	340	646	767	362	356	376
Depreciation and amortization	555	582	572	524	510	564	613	632	595	642
Stock-based compensation	3.25	5.15	5.02	6.91	8.03	11	13.6	8.28	18.4	20.1
Deferred income tax	1.44	-42.2	-13.1	25.9	3.14	10.7	-11.6	13.4	-0.78	-19
Change in receivables	-55.2	-134	80.6	-124	-107	-299	-104	205	99.7	-297
Change in inventory	-8.62	-36.3	-16.3	10.2	-75.5	-191	-148	234	79	-127
Change in payables	48.6	67.6	-43.5	38.7	48.8	216	86.6	-135	-36	203
Cash from operations	729	618	663	564	770	1,121	1,099	1,270	1,089	1,096
Capital expenditures	-650	-551	-547	-472	-553	-780	-908	-749	-744	-905
Acquisitions	0	-43.8	0	0
Purchases of investments	0		-6.48	-5.94	-535	-414	-439	-658	-569	-828
Sales and maturities of investments			4.83	6.47	159	205	371	379
Cash from investing	-589	-455	-537	-462	-639	-944	-1,007	-952	-800	-885
Debt issued	46	224	596	976
Debt repaid	-32.1	-405	-536
Stock issued	8.25
Dividends paid				0	0	-51.2	-55.1	-74.7	-179	-81.9
Cash from financing	-112	-125	-40.6	108	-334	-30.1	55.6	-149	-260	98.7
Exchange rate effect	0.35	8.81	-0.2	0.87	6.06	-18	-16.3	-10.7	-14.4	2.55
Net change in cash	28.1	47.4	85.2	210	-196	129	131	158	13.7	312
Free cash flow	79.4	67.3	116	91.4	217	342	190	521	345	191
Interest paid	86.8	83.8	77.6	66	61.3	46.9	54.4	54.3	60.3	73.6
Income taxes paid	32.2	61.9	63.1	44.5	43.4	24	97.3	90.5	82.6	75.7

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to March 31, 2026; growth uses fiscal years. Valuation uses the share price of $53.61 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	14.4%	Gross profit / revenue.
Operating margin	7.6%	Operating income / revenue.
EBITDA margin	16.9%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	7.3%	Pre-tax income / revenue.
Net margin	6.2%	Net income / revenue.
FCF margin	2.4%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	17.2%	Cash from operations / revenue.
Effective tax rate	14.9%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	9.6%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	5.3%	Net income / average total assets.
Return on invested capital (ROIC)	9.8%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	2.3%	Research and development expense / revenue.
SG&A / revenue	4.5%	Selling, general and administrative expense / revenue.
Capex / revenue	14.8%	Capital expenditures / revenue.
D&A / revenue	9.3%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	6.2%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-1.8%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	5.8%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	0.6%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-11.0%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	0.8%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	6.6%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-19.5%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	0.4%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	7.4%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-9.8%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	2.8%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	5.6%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-21.3%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	2.0%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	4.9%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-21.6%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	1.4%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	0.6%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-0.1%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	7.3%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-44.7%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	0.1%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-2.5%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	-54.2%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	13.8%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	52.7%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	7.7%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	6.8%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	14.0%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	17.2%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	6.0%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	10.1%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.3%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.3%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.5%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.01x	Current assets / current liabilities.
Quick ratio	1.68x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.99x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.28x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	15.1%	Total debt / total assets.
Liabilities / assets	44.9%	Total liabilities / total assets.
Net debt	-$591.3M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	-0.49x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	7.02x	Operating income / interest expense.
Working capital	$1.88B	Current assets - current liabilities.
Goodwill and intangibles / assets	0.2%	(Goodwill + intangible assets) / total assets.
Tangible book value	$4.52B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.85x	Revenue / average total assets.
Fixed asset turnover	1.70x	Revenue / average property, plant and equipment.
Inventory turnover	12.2x	Cost of revenue / average inventory.
Days inventory	30 days	365 x average inventory / cost of revenue.
Receivables turnover	5.49x	Revenue / average receivables.
Days sales outstanding	66 days	365 x average receivables / revenue.
Days payables	50 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	46 days	Days inventory + days sales outstanding - days payables.
FCF conversion	38.3%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	86.3%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$1.75	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$28.33	Revenue / diluted weighted shares.
FCF per share	$0.67	Free cash flow / diluted weighted shares.
Operating cash flow per share	$4.87	Cash from operations / diluted weighted shares.
Book value per share	$18.29	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$18.22	Tangible book value / shares outstanding.
Cash per share	$7.46	(Cash + short-term investments) / shares outstanding.
Payout ratio	23.5%	Dividends paid / net income, when net income is positive.
Dividends / FCF	61.4%	Dividends paid / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$13.32B	Share price x shares outstanding.
Enterprise value	$12.73B	Market cap + total debt - cash - short-term investments.
P/E	30.5x	Market cap / net income. Only when net income is positive.
P/S	1.88x	Market cap / revenue.
P/B	2.94x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	2.95x	Market cap / tangible book value, when positive.
P/FCF	79.7x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	10.9x	Market cap / cash from operations, when positive.
EV/Sales	1.80x	Enterprise value / revenue.
EV/EBIT	23.7x	Enterprise value / operating income, when both are positive.
EV/EBITDA	10.6x	Enterprise value / EBITDA, when both are positive.
EV/FCF	76.1x	Enterprise value / free cash flow, when both are positive.
FCF yield	1.3%	Free cash flow / market cap.
Earnings yield	3.3%	Net income / market cap (the inverse of P/E).
Dividend yield	0.8%	Dividends paid over the period / market cap.
Shareholder yield	0.8%	(Dividends paid + share buybacks) / market cap.

What was AMKOR TECHNOLOGY, INC.'s revenue in fiscal 2025?

AMKOR TECHNOLOGY, INC. reported revenue of $6.71B for fiscal 2025, 6.2% higher than the year before.

Was AMKOR TECHNOLOGY, INC. profitable in fiscal 2025?

Yes. Net income was $373.9M, a net margin of 5.6%.

How much free cash flow did AMKOR TECHNOLOGY, INC. generate in fiscal 2025?

Cash from operations of $1.10B minus capital expenditures of $904.6M left free cash flow of $191.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to AMKOR TECHNOLOGY, INC.